Page results
-
Dr Jonathan Broomberg joined the UCLH Board in January 2025 as a non-executive director. He is currently the CEO of Vitality Health International and Global Head of Health Insurance for the Discovery Group, bringing a wealth of experience in the commercial healthcare sector and global public health and policy.
-
"Patient-initiated follow-up” appointments (PIFU ) allow you to arrange a follow-up appointment if and when you need it.
-
UCLH Charity’s magazine, Charity Matters is out now.
-
This leaflet explains the Catheter Directed Thrombolysis (CDT) procedure at UCLH.
-
Volunteers are being asked to sign up to the latest Covid-19 vaccine study to begin across the UK including at UCLH.
-
The autumn/winter edition of Charity Matters is out now.
-
Two UCLH nurses who have dedicated their entire career to the NHS were invited to attend a VE Day celebration concert last Thursday.
-
Dr Matthew Adams is a consultant radiologist with a special interest in stroke, movement disorders and neurogenetics.
-
The Hyperacute Stroke Unit (HASU) and the Transient Ischaemic Attack (TIA) services were relocated from the seventh floor of University College Hospital to The National Hospital for Neurology and Neurosurgery (NHNN) on 20 March 2020 as part of UCLH’s response to the Covid-19 pandemic.
-
At UCLH, we are extremely proud of our staff and their dedication to delivering the best care for our patients. If you have been treated or looked after by an exceptional member of staff, or a volunteer, we would love you to tell us about it.
File results
-
FOI/2023/0550 - Varicose veins referrals, treatment and wait time
-
FOI/2023/0553 - Maternity complaints by ethnicity
-
FOI/2023/0559 - Patients admitted to hospital with dental distress
-
FOI/2023/0560 - Digital maternity training platform
-
FOI/2023/0561 - Birthrate Plus
-
FOI/2023/0563 - Treatment for Haemophilia B and Von Willebrand disease
-
FOI/2023/0565 - Rare diseases - diagnosis/ treatment for Fabry/ Gaucher/ Pompe
-
FOI/2023/0566 - Structure chart for IM &T, Business Intelligence, Informatics
-
FOI/2023/0569 - Treatment for Ruxolitinib
-
FOI/2023/0578 - Spinal Muscular Atrophy (SMA) patients